COCP

Conviction 42HealthcareScan · Mon, Aug 10, 2026

COCP$1.09+2.83%

ResistanceSupportVol 14Insider buy

Vol MA14 78.27K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Cocrystal Pharma, Inc.PHARMACEUTICAL PREPARATIONSwww.cocrystalpharma.com ↗

Price1.09

Change+2.83%

Gap+9.43%

Rel volume2.35×

Avg volume62.78K

Avg $ vol60.32K

SMA 200.9474

SMA 500.9915

SMA 2001.08

Price vs 50+9.94%

Price vs 200+0.55%

MA stackmixed

50/200 cross—

Supertrendup · 0.8858

RSI (14)65

MACD hist0.03

MACD crossbull · 4d

Stoch %K / %D83 / 89

ADX (14)22

+DI / −DI25 / 25

RSI divergence—

MACD divergence—

ATR %+6.46%

ADR %6.45%

52w high1.70

52w low0.8200

From 52w high-35.69%

Above 52w low+32.93%

New 52w highNo

SqueezeOff

Bollinger width26.65%

%B1.06

Donchian pos82.50%

Donchian high1.16

Donchian low0.7600

AVWAP (52w high)1.67

vs AVWAP high-34.89%

AVWAP (52w low)0.9664

vs AVWAP low+12.79%

OBV trendUp

Chaikin MF (20)-0.15

Today vs 20d2.35×

Avg vol (14d)78.27K

Avg vol (20d)62.78K

Avg $ vol (20d)60.32K

Market cap15.03M

RS 3m (vs SPY)-29.44%

RS 6m (vs SPY)+9.11%

RS line new highNo

Trend template3/8

Technical rank70.2

1 week+15.96%

1 month+7.92%

3 months-24.31%

6 months+12.38%

1 year-33.94%

YTD+9.79%

P/E-1.70

P/B3.65

P/S7.46

P/FCF-1.83

EPS-0.7800

Div yield—

ROE-214.55%

ROA-118.92%

Debt/Eq12.17

Current2.66

EV/EBITDA—

Gross margin358.57%

Net margin-438.48%

Rev growth0.00%

EPS growth49.55%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value58.1M

Revenue489K

Net income-2.3M

Gross profit1.11M

Free cash flow-8.2M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out13.79M

Employees10

ListedTue, Apr 1, 2008

Free float10.27M

Float %74.5%

Short interest395.02K

Days to cover14.9d

Short volume33.0%

Squeeze score48 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction42 / 100

Pattern quality—

Tech rank70.2 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.07

Support0.8300

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in COCP

All disclosures →

No recent disclosed trades by Congress in COCP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in COCP · 2 buys

Insider	Side	Shares	Value	Traded	Filed
FROST PHILLIP MD ET AL Director · Common Stock · 2026-08-03	Buy	75K	$71K	2026-08-03	2026-08-05
SAPIRSTEIN JAMES Chief Executive Officer · Stock Options (Right to Buy) · 2026-06-03	Grant	235K	$0	2026-06-03	2026-06-03

SEC filings

EDGAR filings in COCP · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.